Journal
PERITONEAL DIALYSIS INTERNATIONAL
Volume 32, Issue 6, Pages 595-604Publisher
MULTIMED INC
DOI: 10.3747/pdi.2012.00046
Keywords
Dialysis timing; mortality; outcomes; peritonitis
Categories
Funding
- National Health and Medical Research Council of Australia [211146, 465095]
- Australian Health Ministers Advisory Council [PDR 2001/10]
- Royal Australasian College of Physicians/Australian
- New Zealand Society of Nephrology
- National Heart Foundation (Australia)
- National Heart Foundation (New Zealand)
- Baxter Healthcare Corporation
- Health Funding Authority New Zealand (Te Mana Putea Hauora O Aotearoa)
- International Society for Peritoneal Dialysis
- Amgen Australia Pty Ltd.
- Janssen Cilag Pty Ltd.
- Baxter Healthcare
- Amgen
- Roche
- Abbott
- Boehringer Ingelheim
- Lilley
- AstraZeneca
- Fresenius Medical Care
- Amgen Australia
Ask authors/readers for more resources
Background: Since the mid-1990s, early dialysis initiation has dramatically increased in many countries. The Initiating Dialysis Early and Late (IDEAL) study demonstrated that, compared with late initiation, planned early initiation of dialysis was associated with comparable clinical outcomes and increased health care costs. Because residual renal function is a key determinant of outcome and is better preserved with peritoneal dialysis (PD), the present pre-specified subgroup analysis of the IDEAL trial examined the effects of early-compared with late-start dialysis on clinical outcomes in patients whose planned therapy at the time of randomization was PD. Methods: Adults with an estimated glomerular filtration rate (eGFR) of 10 - 15 mL/min/1.73 m(2) who planned to be treated with PD were randomly allocated to commence dialysis at an eGFR of 10 - 14 mL/min/1.73 m2 (early start) or 5 - 7 mL/min/1.73 m2 (late start). The primary outcome was all-cause mortality. Results: Of the 828 IDEAL trial participants, 466 (56%) planned to commence PD and were randomized to early start (n = 233) or late start (n = 233). The median times from randomization to dialysis initiation were, respectively, 2.03 months [interquartile range (IQR): 1.67 - 2.30 months] and 7.83 months (IQR: 5.83 - 8.83 months). Death occurred in 102 early-start patients and 96 late-start patients [hazard ratio: 1.04; 95% confidence interval (CI): 0.79 - 1.37]. No differences in composite cardiovascular events, composite infectious deaths, or dialysis-associated complications were observed between the groups. Peritonitis rates were 0.73 episodes (95% CI: 0.65 - 0.82 episodes) per patient-year in the early-start group and 0.69 episodes (95% CI: 0.61 - 0.78 episodes) per patient-year in the late-start group (incidence rate ratio: 1.19; 95% CI: 0.86 - 1.65; p = 0.29). The proportion of patients planning to commence PD who actually initiated dialysis with PD was higher in the early-start group (80% vs 70%, p = 0.01). Conclusion: Early initiation of dialysis in patients with stage 5 chronic kidney disease who planned to be treated with PD was associated with clinical outcomes comparable to those seen with late dialysis initiation. Compared with early-start patients, late-start patients who had chosen PD as their planned dialysis modality were less likely to commence on PD. Perit Dial Int 2012; 32(6): 595-604 www.PDIConnect.com doi:10.3747/pdi.2012.00046
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available